Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MMP3 | P08254 | 2/20 | 0.53 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28126646 | 0.86 | LDHA (0.68) | LDHAALDH1A1F2RL1SMN1; SMN2HTT | |
| SCHEMBL7676917 | 0.83 | LDHA (0.59) | LDHAALDH1A1F2RL1SMN1; SMN2HTT | |
| SCHEMBL3739740 | 0.83 | LDHA (0.59) | LDHAALDH1A1F2RL1SMN1; SMN2HTT | |
| SCHEMBL8283100 | 0.82 | LDHA (0.73) | LDHAMMP3FFAR1 | |
| SCHEMBL663059 | 0.82 | LDHA (0.73) | LDHAMMP3FFAR1 | |
| SCHEMBL14920749 | 0.82 | TSHR (0.67) | ALDH1A1MMP3F2RL1SMN1; SMN2HTT | |
| SCHEMBL6950447 | 0.81 | KIF11 (0.57) | LDHAALDH1A1F2RL1SMN1; SMN2FFAR1 | |
| SCHEMBL6942606 | 0.81 | KIF11 (0.57) | LDHAALDH1A1F2RL1SMN1; SMN2FFAR1 | |
| SCHEMBL18071078 | 0.81 | KIF11 (0.57) | LDHAALDH1A1F2RL1SMN1; SMN2FFAR1 | |
| SCHEMBL8199902 | 0.81 | LDHA (0.57) | LDHAALDH1A1F2RL1SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12215088-B2 | Method for the industrial production of 2-halo-4,6-dialkoxy-1,3,5-triazines and their use in the presence of amines | CROSSING SRL (IT) | 2025-02-04 | — | — | US | disclosed |
| US-20250026728-A1 | METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES | CROSSING SRL (IT) | 2025-01-23 | — | — | US | disclosed |
| US-20210355091-A1 | METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES | CROSSING SRL (IT) | 2021-11-18 | — | — | US | disclosed |
| US-11111221-B2 | Method for the industrial production of 2-halo- 4,6-dialkoxy-l,3,5-triazines and their use in the presence of amines | CROSSING SRL (IT) | 2021-09-07 | — | — | US | disclosed |
| EP-3524596-B1 | REAGENTS COMPRISING 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES IN THE PRESENCE OF AMINES AND THEIR USE IN A STABILIZATION METHOD. | CROSSING SRL (IT) | 2020-09-09 | — | — | EP | disclosed |
| EP-3524596-A1 | REAGENTS COMPRISING 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES IN THE PRESENCE OF AMINES AND THEIR USE IN A STABILIZATION METHOD. | Crossing S.r.l. (IT) | 2019-08-14 | — | — | EP | disclosed |
| EP-3237390-B1 | METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINE AND THEIR USE IN THE PRESENCE OF AMINES | CROSSING S R L (IT) | 2019-05-08 | — | — | EP | disclosed |
| US-20190077774-A1 | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS | HOPE CITY (US) | 2019-03-14 | — | — | US | disclosed |
| US-20180370924-A1 | METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES | CROSSING SRL (IT) | 2018-12-27 | — | — | US | disclosed |
| EP-3237390-A2 | METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINE AND THEIR USE IN THE PRESENCE OF AMINES | Crossing S.r.l. (IT) | 2017-11-01 | — | — | EP | disclosed |
| WO-2016103185-A2 | METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO -4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES | CROSSING SRL (IT) | 2016-06-30 | — | — | WO | disclosed |
| CN-1582279-A | Peroxisome-activated receptor agonists | LILLY CO ELI (US) | 2005-02-16 | — | — | CN | disclosed |
| CN-1437587-A | Benzoxazepinones and their use as squalene synthetase inhibitors | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-08-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180370924-A1 | METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES | COL2A1, COL1A1, WIZ | LDHA 4277/4885ALDH1A1 1828/4885MMP3 2293/4885 |
| US-11111221-B2 | Method for the industrial production of 2-halo- 4,6-dialkoxy-l,3,5-triazines and their use in the presence of amines | COL2A1, WIZ, HDHD5 | LDHA 3908/4885ALDH1A1 2094/4885MMP3 2203/4885 |
| US-12215088-B2 | Method for the industrial production of 2-halo-4,6-dialkoxy-1,3,5-triazines and their use in the presence of amines | COL2A1, COL1A1, WIZ | LDHA 4277/4885ALDH1A1 1828/4885MMP3 2293/4885 |
| US-20190077774-A1 | PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS | PPARG, PPARA, PPARD | LDHA 815/4885ALDH1A1 551/4885MMP3 2454/4885 |
| US-20210355091-A1 | METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES | COL2A1, COL1A1, IDUA | LDHA 4064/4885ALDH1A1 2244/4885MMP3 2447/4885 |
| US-20250026728-A1 | METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES | COL2A1, COL1A1, COL14A1 | LDHA 4244/4885ALDH1A1 1877/4885MMP3 1999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.